Fair Value Measurements (Narrative) (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended			3 Months Ended		1 Months Ended
	Sep. 30, 2013	Sep. 30, 2013 Rising Pharmaceuticals Inc. [Member]	Jun. 30, 2013 Rising Pharmaceuticals Inc. [Member]	Sep. 30, 2013 Foreign Currency Contract [Member]	Sep. 30, 2012 Foreign Currency Contract [Member]	Mar. 31, 2011 Interest Rate Swap [Member] Cash Flow Hedging [Member]	Sep. 30, 2013 Interest Rate Swap [Member] Cash Flow Hedging [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount				$ 64,378		$ 20,000	$ 11,250
Unrealized gains (losses) on hedging activities				381	(61)
Derivative, expiration date						Dec. 31, 2015
Unrealized loss on interest rate swap	227
Contingent consideration at fair value		$ 5,473	$ 5,346